Interestingly, the probe selected by Random Forest, myeloperoxidase, is a cytochemical marker for the diagnosis (and also potentially the prognosis) of acute myeloid leukemia (AML; Matsuo et al., 2003). Here, MPO is linked to acute myeloid leukemia.